1 not yet recruiting, 1 recruiting. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow VT3989: new trials by email Literature Review of VT3989 trials Research Report on VT3989
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Trial in Advanced Epithelioid Mesothelioma VT3989, gemcitabine, Vinorelbine - Pleural Mesothelioma, Mesothelioma | Phase 3 | Not yet recruiting | Vivace Therapeutics, Inc | 350 | 2026-12-01 | 2026-09-17 |
| Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors VT3989, Nivolumab & Ipilimumab, Osimertinib - Solid Tumor, Adult, Mesothelioma | Phase 1 / Phase 2 | Recruiting | Vivace Therapeutics, Inc | 434 | 2021-03-24 | 2026-04-02 |
Mesothelioma (2) · Mesothelioma, Malignant (1)
Australia (1) · United States (1)